Clinical Trial Update: ImmunoTEP for Patients With Medullary Thyroid Carcinoma. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for ImmunoTEP in patients with Medullary Thyroid Carcinoma (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medullary Thyroid Carcinoma

Drugs mentioned

• ImmunoTEP

Snippet

Sponsor: Nantes University Hospital | Conditions: Medullary Thyroid Carcinoma | Phase 1, Phase 2 | Status: COMPLETED